Cogent Biosciences, Inc.
COGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $810,082 | $468,383 | $679,031 | $332,310 |
| - Cash | $98,165 | $53,229 | $139,886 | $219,684 |
| + Debt | $17,467 | $18,853 | $19,649 | $3,155 |
| Enterprise Value | $729,384 | $434,007 | $558,794 | $115,781 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$271,588 | -$204,542 | -$141,961 | -$73,560 |
| % Margin | – | – | – | – |
| Net Income | -$255,859 | -$192,410 | -$140,241 | -$72,273 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.46 | -2.42 | -2.26 | -1.85 |
| % Growth | -1.7% | -7.1% | -22.2% | – |
| Operating Cash Flow | -$207,791 | -$153,624 | -$118,638 | -$58,763 |
| Capital Expenditures | -$573 | -$2,796 | -$6,863 | -$1,719 |
| Free Cash Flow | -$208,364 | -$156,420 | -$125,501 | -$60,482 |